Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-07-19

Clinical Trial Update: A Study to Evaluate the Relative Bioavailability and Food Effect of a New Tablet Formulation and Strength of Suzetrigine [Phase 1]

View source ↗

Summary

Phase 1 study evaluating the relative bioavailability and food effect of a new tablet formulation and strength of Suzetrigine has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Suzetrigine (Suzetrigine)

Snippet

Sponsor: Vertex Pharmaceuticals Incorporated | Conditions: Pain | Phase 1 | Status: COMPLETED